The novel estrogen receptor-beta subtype: potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens
- PMID: 9247129
- DOI: 10.1016/s0014-5793(97)00413-4
The novel estrogen receptor-beta subtype: potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens
Abstract
The recent discovery that an additional estrogen receptor (ER) subtype is present in various rat, mouse and human tissues has advanced our understanding of the mechanisms underlying estrogen signalling. The discovery of a second ER subtype (ERbeta) suggests the existence of two previously unrecognised pathways of estrogen signalling: via the ERbeta subtype in tissues exclusively expressing this subtype and via the formation of heterodimers in tissues expressing both ER subtypes. Various models have been suggested as explanations for the striking cell- and promoter-specific effects of estrogens and anti-estrogens, all on the basis of the assumption that only a single ER gene exists. This minireview describes several of these models and focuses on the potential role which the novel ERbeta subtype might have in this regard.
Similar articles
-
The estrogen receptor beta subtype: a novel mediator of estrogen action in neuroendocrine systems.Front Neuroendocrinol. 1998 Oct;19(4):253-86. doi: 10.1006/frne.1998.0170. Front Neuroendocrinol. 1998. PMID: 9799586 Review.
-
[Estrogen biosynthesis and receptors].Ann Endocrinol (Paris). 1999 Nov;60(5):381-91. Ann Endocrinol (Paris). 1999. PMID: 10615517 Review. French.
-
The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens.Endocrinology. 1999 Dec;140(12):5566-78. doi: 10.1210/endo.140.12.7179. Endocrinology. 1999. PMID: 10579320
-
Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.Mol Endocrinol. 1999 Mar;13(3):418-30. doi: 10.1210/mend.13.3.0253. Mol Endocrinol. 1999. PMID: 10076999
-
Estrogen receptor beta acts as a dominant regulator of estrogen signaling.Oncogene. 2000 Oct 12;19(43):4970-8. doi: 10.1038/sj.onc.1203828. Oncogene. 2000. PMID: 11042684
Cited by
-
The biological actions of dehydroepiandrosterone involves multiple receptors.Drug Metab Rev. 2006;38(1-2):89-116. doi: 10.1080/03602530600569877. Drug Metab Rev. 2006. PMID: 16684650 Free PMC article. Review.
-
Diarylpropionitrile (DPN) enantiomers: synthesis and evaluation of estrogen receptor β-selective ligands.J Med Chem. 2012 Jan 12;55(1):528-37. doi: 10.1021/jm201436k. Epub 2011 Dec 14. J Med Chem. 2012. PMID: 22122563 Free PMC article.
-
The hop phytoestrogen, 8-prenylnaringenin, reverses the ovariectomy-induced rise in skin temperature in an animal model of menopausal hot flushes.J Endocrinol. 2006 Nov;191(2):399-405. doi: 10.1677/joe.1.06919. J Endocrinol. 2006. PMID: 17088409 Free PMC article.
-
Associations between estrogen receptor genetic polymorphisms, smoking status, and prostate cancer risk: a case-control study in Japanese men.Environ Health Prev Med. 2015 Sep;20(5):332-7. doi: 10.1007/s12199-015-0471-5. Epub 2015 Aug 7. Environ Health Prev Med. 2015. PMID: 26251204 Free PMC article.
-
Antiestrogens--tamoxifen, SERMs and beyond.Invest New Drugs. 1999;17(3):285-311. doi: 10.1023/a:1006348907994. Invest New Drugs. 1999. PMID: 10665480 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources